Mabcampath and oedema peripheral Patient Reports February 11, 2012

Mabcampath Side Effects Report #6038164-9
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Jan 05, 2009. Female patient, 80 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: erythema, oedema peripheral, pain in extremity, pruritus, pyrexia, rash , skin lesion. Mabcampath dosage: unknown. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #6041914-9
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Jan 08, 2009. Female patient, 80 years of age, was diagnosed with chronic lymphocytic leukaemia, osteoarthritis  and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: erythema, fatigue, headache , oedema peripheral, pain in extremity, pruritus, pyrexia, rash , skin lesion. Mabcampath dosage: unknown. During the same period patient was treated with KETOPROFEN. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5650517-7
Mabcampath side effect was reported by a Consumer or non-health professional from GERMANY on Feb 13, 2008. Female patient, 62 years of age, weighting 152.1 lb, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, aphthous stomatitis, immunodeficiency, leukopenia, oedema peripheral, pain , pneumonia primary atypical, pyrexia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5657074-X
Mabcampath side effect was reported by a Consumer or non-health professional from GERMANY on Feb 13, 2008. Female patient, 62 years of age, weighting 152.1 lb, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, aphthous stomatitis, immunodeficiency, leukopenia, oedema peripheral, pain , pneumonia primary atypical, relapsing fever. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.


Mabcampath Side Effects Report #5298194-1
Mabcampath side effect was reported by a Consumer or non-health professional from CANADA on Apr 08, 2007. Female patient, 52 years of age, was treated with Mabcampath. After drug was administered, patient experienced the following side effects: gait disturbance, injection site cellulitis, injection site erythema, injection site mass, injection site pain, injection site swelling, local swelling, oedema peripheral. Mabcampath dosage: 3 MG, DOSE ESCALATION. During the same period patient was treated with TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.